Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial

NCT04382625 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Secondary to other study results, suspended for a scientific review

Conditions

SARS-CoV-2 Pneumonia
COVID-19

Interventions

DRUG: Hydroxychloroquine

Sponsor

Kootenai Health

Collaborators

[object Object]